Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bank of Montreal Can

Bank of Montreal Can cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.2% during the third quarter, HoldingsChannel.com reports. The firm owned 839,762 shares of the medical equipment provider’s stock after selling 254,193 shares during the period. Bank of Montreal Can’s holdings in Intuitive Surgical were worth $402,397,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Fisher Asset Management LLC increased its holdings in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares in the last quarter. Baillie Gifford & Co. increased its stake in Intuitive Surgical by 0.6% in the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. American Century Companies Inc. raised its holdings in Intuitive Surgical by 3.0% during the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock worth $1,066,837,000 after purchasing an additional 70,556 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Intuitive Surgical by 1.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,227,467 shares of the medical equipment provider’s stock worth $1,094,288,000 after purchasing an additional 28,703 shares in the last quarter. Finally, Clearbridge Investments LLC grew its holdings in Intuitive Surgical by 1.6% in the second quarter. Clearbridge Investments LLC now owns 1,981,297 shares of the medical equipment provider’s stock valued at $881,380,000 after purchasing an additional 30,449 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research reports. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Leerink Partners increased their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, Truist Financial increased their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded down $7.46 during trading hours on Monday, reaching $540.41. 207,294 shares of the company were exchanged, compared to its average volume of 1,450,479. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00. The stock has a 50 day simple moving average of $504.73 and a 200 day simple moving average of $464.13. The firm has a market cap of $192.48 billion, a price-to-earnings ratio of 88.08, a PEG ratio of 5.39 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This trade represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,539 shares of company stock valued at $26,112,364 in the last three months. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.